75
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

High Expression of WT1 and Low Expression of p53 in Archived Blocks of Children with Wilms Tumor in South Western Uganda

ORCID Icon, , ORCID Icon, , , , & show all
Pages 127-136 | Received 04 Dec 2023, Accepted 29 Feb 2024, Published online: 05 Mar 2024

References

  • American cancer society cancer facts and figures. Available from: https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2022.html. Accessed November 18.
  • Diakité F, Togo P, Doumbia A, et al. Prevalence and Prognosis of relapse of nephroblastoma at the pediatric oncology unit of Bamako. Open J Pediatr. 2019;9(04):317. doi:10.4236/ojped.2019.94031
  • Stefan DC. Patterns of distribution of childhood cancer in Africa. J Trop Pediatr. 2015;61(3):165–173. doi:10.1093/tropej/fmv005
  • Mbarara Regional Referral Hospital Pediatric oncology, Soid tumors. Mbarara regional referral hospital mbarara regional referral hospital; 2021.
  • Vujanić GM, D’Hooghe E, Popov SD, Sebire NJ, Kelsey A. The effect of preoperative chemotherapy on histological subtyping and staging of Wilms tumors: the United Kingdom Children’s Cancer Study Group (UKCCSG) Wilms tumor trial 3 (UKW3) experience. Pediatr Blood Cancer. 2019;66(3):e27549. doi:10.1002/pbc.27549
  • Dome JS, Cotton CA, Perlman EJ, et al. Treatment of anaplastic histology Wilms’ tumor: results from the fifth National Wilms’ Tumor Study. J Clin Oncol. 2006;24(15):2352–2358. doi:10.1200/JCO.2005.04.7852
  • Kumar V, Abbas AK, Fausto N, Aster JC. Robbins and Cotran Pathologic Basis of Disease, Professional Edition e-Book. Elsevier health sciences; 2014.
  • Daniel WW, Cross CL. Biostatistics: A Foundation for Analysis in the Health Sciences. Wiley; 2018.
  • Angucia B, Nabwana M, Asasira J, Mulumba Y, Mutyaba I, Jackson O. Spectrum of primary cancer diagnoses among patients at Uganda Cancer Institute in 2015 and 2016. Am Soc Clin Oncol. 2018;2018:1.
  • Vujanić GM, Sandstedt B. The pathology of Wilms’ tumour (nephroblastoma): the International Society of Paediatric Oncology approach. J Clin Pathol. 2010;63(2):102–109. doi:10.1136/jcp.2009.064600
  • Lahoti C, Thorner P, Malkin D, Yeger H. Immunohistochemical detection of p53 in Wilms’ tumors correlates with unfavorable outcome. Am J Pathol. 1996;148(5):1577.
  • Goyal S, Mishra K, Sarkar U, Sharma S, Kumari A. Diagnostic utility of Wilms’ tumour-1 protein (WT-1) immunostaining in paediatric renal tumours. Indian J Med Res. 2016;143(Suppl 1):S59. doi:10.31254/jmr.2016.2304
  • Weirich A, Leuschner I, Harms D, et al. Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9/GPOH. Ann Oncol. 2001;12(3):311–319. doi:10.1023/a:1011167924230
  • Zuppan CW, Weeks DA, Weeks DA, et al. The effect of preoperative therapy on the histologic features of Wilms’ tumor. An analysis of cases from the Third National Wilms’ Tumor Study. Cancer. 1991;68(2):385–394. doi:10.1002/1097-0142(19910715)68:2<385::aid-cncr2820680229>3.0.co;2-t
  • Darwish A, Alemam D, Sheta H. Role of expression of p53 and Ki67 in the progression of Wilms tumor: correlation with patients’ survival. Int J Cancer Biomed Res. 2021;5(2):99–110.
  • Atanda AT, Anyanwu L-JC, Atanda OJ, Mohammad AM, Abdullahi LB, Farinyaro AU. Wilms’ tumour: determinants of prognosis in an African setting. Afr J Paediatr Surg. 2015;12(3):171. doi:10.4103/0189-6725.170185
  • Salama A, Kamel A. Evaluation of nuclear unrest and p53 immunostaining in Wilms’ tumor. J Egypt Natl Canc Inst. 2011;23(1):31–39.
  • Morgan ED, Yahaya JJ, Ngaiza AI, et al. Immunohistochemical expression of P53 protein in nephroblastoma: a predictor of unfavorable prognosis. J Egypt Natl Canc Inst. 2023;35(1):23.
  • Okello I, Tibenderana R, Lubega A, Tuhairwe E, Situma M. Wilms tumour among children attending Mbarara Regional Referral Hospital: clinico-pathological characteristics and outcome at the end of treatment. East Central Afr J Surg. 2019;24(1):28–34.
  • Huang J, Zhang Y, Zhen Z, et al. The prognosis of prechemotherapy blastemal predominant histology subtype in Wilms tumor: a retrospective study in China. Pediatr Blood Cancer. 2020;67(11):e28567. doi:10.1002/pbc.28567
  • Murphy AJ, Axt JR, de Caestecker C, et al. Molecular characterization of Wilms’ tumor from a resource‐constrained region of sub-Saharan Africa. Int J Cancer. 2012;131(6):E983–E994. doi:10.1002/ijc.27544
  • Ekuk E, Odongo CN, Tibaijuka L, et al. One year overall survival of Wilms tumor cases and its predictors, among children diagnosed at a teaching hospital in South Western Uganda: a retrospective cohort study. BMC Cancer. 2023;23(1):1–10.
  • Krishna O, Kayla G, Abdul Aleem M, et al. Immunohistochemical expression of Ki67 and p53 in Wilms tumor and its relationship with tumor histology and stage at presentation. Pathol Res Int. 2016;2016. doi:10.1155/2016/6123951
  • Das RN, Chatterjee U, Sinha SK, et al. Study of histopathological features and proliferation markers in cases of Wilms′ tumor. Indian J Med Paediatr Oncol. 2012;33(02):102–106.
  • Oue T, Uehara S, Yamanaka H, et al. Expression of Wilms tumor 1 gene in a variety of pediatric tumors. J Pediatr Surg. 2011;46(12):2233–2238. doi:10.1016/j.jpedsurg.2011.09.004
  • Govender D, Harilal P, Hadley G, et al. p53 protein expression in nephroblastomas: a predictor of poor prognosis. Br J Cancer. 1998;77(2):314–318. doi:10.1038/bjc.1998.48
  • Hill DA, Shear TD, Liu T, et al. Clinical and biologic significance of nuclear unrest in Wilms tumor. Cancer. 2003;97(9):2318–2326. doi:10.1002/cncr.11325
  • Dome JS, Perlman EJ, Graf N. Risk stratification for Wilms tumor: current approach and future directions. Am Soc Clin Oncol Educ Book. 2014;34(1):215–223.